Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

App alerts doctors to cancer symptoms in real time

NCT ID NCT06867705

Symptom relief Sponsor: Resilience Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a smartphone app called Resilience PRO can improve quality of life for cancer patients receiving chemotherapy or other systemic treatments. About 1,458 adults with any stage of cancer will either use the app to report symptoms (with alerts sent to their care team) or receive usual care alone. The goal is to see if digital monitoring helps manage symptoms better and improves overall well-being.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 1,458 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: Adults ≥ 18 years. * Informed Consent: Patient giving signed informed consent to participate in the RC - 102 clinical study. * Diagnosis: Patients with cancer at any stage. * Systemic Treatment * Remote Monitoring Eligibility: Access to a smartphone * Language: Ability to understand and communicate in the language(s) in which the trial is conducted. Exclusion Criteria: * Age: Patients under 18 years of age. * Life Expectancy: Patients with a life expectancy of less than 6 months as estimated by the treating physician. * Concurrent remote monitoring * HSCT or CAR-T Therapy * Cognitive Impairment * Pregnancy or breastfeeding * Subject under administrative or judicial control

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    36 sites in 2 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • AP-HM Assistance Publique - Hôpitaux de Marseille Hôpital de la Timone

    RECRUITING

    Marseille, 13005, France

  • AP-HP Hôpitaux Universitaires La Pitié Salpêtrière

    RECRUITING

    Paris, 75013, France

  • Centre Clinical Elsan

    RECRUITING

    Soyaux, 16800, France

  • Centre Hospitalier Henri Mondor-Aurillac

    RECRUITING

    Aurillac, 15000, France

  • Centre Hospitalier Intercommunal Toulon - La Seyne sur Mer

    RECRUITING

    Toulon, 83056, France

  • Centre Hospitalier Universitaire Grenoble - Alpes

    RECRUITING

    La Tronche, 38700, France

  • Centre Hospitalier Universitaire Sud Réunion

    RECRUITING

    Saint-Pierre, 97448, France

  • Centre Hospitalier Universitaire de Caen Normandie

    RECRUITING

    Caen, 14033, France

  • Centre Hospitalier Universitaire de Clermont-Ferrand

    RECRUITING

    Clermont-Ferrand, 63003, France

  • Centre Hospitalier Universitaire de Lille

    RECRUITING

    Lille, 59037, France

  • Centre Hospitalier Universitaire de Nantes

    RECRUITING

    Nantes, 44093, France

  • Centre Hospitalier Universitaire de Nice

    RECRUITING

    Nice, 06000, France

  • Centre Hospitalier Universitaire de Nîmes

    RECRUITING

    Nîmes, 30029, France

  • Centre Hospitalier de la Côte Basque

    RECRUITING

    Bayonne, 64100, France

  • Centre Hospitalier du Pays d'Aix - Centre Hospitalier Intercommunal Aix-Pertuis

    RECRUITING

    Aix-en-Provence, 13100, France

  • Centre de Cancérologie Les Dentellières

    RECRUITING

    Valenciennes, 59300, France

  • Clinique Mutualiste Bretagne Occidentale

    RECRUITING

    Quimper, 29000, France

  • Clinique Mutualiste de l'Estuaire

    RECRUITING

    Saint-Nazaire, 44606, France

  • Clinique Pasteur

    RECRUITING

    Toulouse, 31076, France

  • Clinique Teissier

    RECRUITING

    Valenciennes, 59300, France

  • GHICL Hôpital Saint Vincent de Paul

    RECRUITING

    Lille, 59000, France

  • Gustave Roussy

    RECRUITING

    Villejuif, 94805, France

  • Helios Klinikum Bad Saarow

    RECRUITING

    Bad Saarow, 15526, Germany

  • Hôpital Privé Jean Mermoz - Institut de Cancérologie

    RECRUITING

    Lyon, 69008, France

  • Hôpital Privé de Provence

    RECRUITING

    Aix-en-Provence, 13080, France

  • Hôpital Privé de la Loire (HPL) - Saint Etienne

    RECRUITING

    Saint-Etienne, 42100, France

  • Hôpital Privé du Confluent

    RECRUITING

    Nantes, 44200, France

  • Katholisches Klinikum Bochum UK St. Josef - Hospital

    RECRUITING

    Bochum, 44791, Germany

  • MVZ Aschaffenburg-Alzenau

    RECRUITING

    Hösbach, 63768, Germany

  • Medizinische Hochschule Hannover

    RECRUITING

    Hanover, 30625, Germany

  • Onkomedeor MVZ Perlach

    RECRUITING

    München, 81737, Germany

  • UK Hamburg- Eppendorf (UKE)

    RECRUITING

    Hamburg, 20246, Germany

  • University Hospital Augsburg - UKA

    RECRUITING

    Augsburg, 86156, Germany

  • Universitätsklinikum Schleswig-Holstein (UKSH), Campus Kiel

    RECRUITING

    Kiel, 24105, Germany

  • Universitätsklinikum Schleswig-Holstein (UKSH), Campus Lübeck

    RECRUITING

    Lübeck, 23538, Germany

  • Universitätsklinikum Tuebingen

    RECRUITING

    Tübingen, 72076, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.